Everest Medicines Limited (1952.HK)
HKD 48.8
(3.61%)
HKD 48.8
(3.61%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.70 CNY | -225.3% |
| 2022 | -0.83 CNY | 76.01% |
| 2021 | -3.46 CNY | 86.92% |
| 2020 | -26.46 CNY | -3791.18% |
| 2019 | -0.68 CNY | 80.57% |
| 2018 | -3.50 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.98 CNY | 0.0% |
| 2024 Q1 | -0.98 CNY | -50.77% |
| 2023 Q4 | -0.65 CNY | 0.0% |
| 2023 Q2 | -0.70 CNY | 0.0% |
| 2023 FY | - CNY | -225.3% |
| 2023 Q1 | -0.70 CNY | -200.0% |
| 2023 Q3 | -0.65 CNY | 7.14% |
| 2022 Q3 | 0.70 CNY | 161.95% |
| 2022 Q4 | 0.70 CNY | 0.0% |
| 2022 Q2 | -1.13 CNY | 0.0% |
| 2022 FY | - CNY | 76.01% |
| 2022 Q1 | -1.13 CNY | -5.61% |
| 2021 Q3 | -1.07 CNY | -64.62% |
| 2021 Q2 | -0.65 CNY | 0.0% |
| 2021 FY | - CNY | 94.8% |
| 2021 Q1 | -0.65 CNY | 96.23% |
| 2021 Q4 | -1.07 CNY | 0.0% |
| 2020 FY | - CNY | -9689.71% |
| 2020 Q3 | -11.72 CNY | -256.23% |
| 2020 Q2 | -3.29 CNY | -407.48% |
| 2020 Q4 | -17.26 CNY | -47.27% |
| 2020 Q1 | 1.07 CNY | 0.0% |
| 2019 FY | - CNY | 80.57% |
| 2019 Q1 | 0.35 CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 24424.324% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 150100.0% |